Abcam boosts drug addiction research
Abcam Biochemicals will provide the FFN compounds to its customers to support both fundamental and applied neurobiological research, including neurodegeneration and drug addiction. The FFNs licenced by Abcam are first-of-a-kind small molecules that …
Read more on Business Weekly

NIH study sheds light on how to reset the addicted brain
The study, published in Nature, was conducted by scientists at the Intramural Research Program of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the University of California, San Francisco. “This exciting …
Read more on National Institutes of Health (press release)

Public Invited to Free UAMS Drug Symposium
Little Rock, AR – The public is invited to hear about the latest drug addiction research, treatment and policy at an April 15 symposium at the University of Arkansas for Medical Sciences (UAMS) featuring a national leader in drug addiction science and …
Read more on KARK